Estonia vs Mauritius: The number of people with susceptibility test result for rifampicin
Estonia
74
in 2021
Mauritius
83
in 2021
Estonia rank
113th
Mauritius rank
112th
The number of people with susceptibility test result for rifampicin over time
- Estonia
- Mauritius
How they compare
Mauritius currently reports 83 against 74 in Estonia, a difference of 9.
That makes Mauritius's figure about 1.1 times Estonia's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Estonia ahead.
Estonia ranks 113th and Mauritius ranks 112th of 155 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 111 | 0 | — |
| 2020s | 82.5 | 83 | 0.5 | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Estonia or Mauritius?
- Mauritius, at 83 against 74 in Estonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Estonia and Mauritius?
- 9, with Mauritius ahead.
- How many years of comparable data are there for Estonia and Mauritius?
- 5 years are reported by both, from 2017 to 2021.
- How do Estonia and Mauritius rank globally for the number of people with susceptibility test result for rifampicin?
- Estonia ranks 113th and Mauritius ranks 112th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.